These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 855811)

  • 41. Prospective carbohydrate metabolism studies in women using a low-estrogen oral contraceptive for one year.
    Spellacy WN; Birk SA; Buggie J; Buhi WC
    J Reprod Med; 1981 Jun; 26(6):295-8. PubMed ID: 7019435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of ethynodiol diacetate and a combination-type oral contraceptive compound on carbohydrate metabolism. II. One year intravenous glucose tolerance study.
    Goldman JA
    Diabetologia; 1977 Apr; 13(2):89-91. PubMed ID: 856654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of oral contraceptive use with the effects of age, exercise habits and other cardiovascular risk modifiers on metabolic risk markers.
    Godsland IF
    Contraception; 1996 Jan; 53(1):9-16. PubMed ID: 8631192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum lipid studies in women using combination type of oral contraceptives.
    Vaidya R; Purandare VN; Nain S; Gupta K; Rajwade N; Sheth UK
    J Obstet Gynaecol India; 1979 Jun; 29(3):644-6. PubMed ID: 12335922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of a once-a-week steroid contraceptive (R2323) on lipid and carbohydrate metabolism in women during three months of use.
    Spellacy WN; Buhi WC; Dumbaugh VA; Birk SA
    Fertil Steril; 1978 Sep; 30(3):289-92. PubMed ID: 710600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
    Weinberger MH; Kramer NJ; Grim CE; Petersen LP
    J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.
    Petersen KR; Christiansen E; Madsbad S; Skouby SO; Andersen LF; Jespersen J
    Contraception; 1999 Dec; 60(6):337-44. PubMed ID: 10715368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term profile of a new progestin.
    Lippman J
    Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies of carbohydrate and lipid metabolism in women using the progesterone-T intrauterine device for six months: blood glucose, insulin, cholesterol, and triglyceride levels.
    Spellacy WN; Buhi WC; Birk SA
    Fertil Steril; 1978 May; 29(5):505-8. PubMed ID: 668930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Active and inactive renin in pregnancy and in women on estrogen-containing oral contraceptives.
    Hayashi M; Saruta T; Nakamura R; Saito I; Kondo K; Kato E
    Gynecol Obstet Invest; 1979; 10(5):246-53. PubMed ID: 395034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbohydrate and lipid studies during six months' treatment with megestrol acetate. Measurements of blood glucose, insulin, growth hormone, and triglycerides.
    Spellacy WN; Newton RE; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1973 Aug; 116(8):1074-8. PubMed ID: 4721135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of oral contraceptives on serum lipids.
    Schenker JG; Pinson A; Polishuk WZ
    Fertil Steril; 1971 Sep; 22(9):604-8. PubMed ID: 5571067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of estrogen/progestin agents on plasma retinoids and chylomicron remnant metabolism.
    Gleeson JM; Dukes CS; Elstad NL; Chan IF; Wilson DE
    Contraception; 1987 Jan; 35(1):69-78. PubMed ID: 3568661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased blood viscosity in young women using oral contraceptives.
    Lowe GD; Drummond MM; Forbes CD; Barbenel JC
    Am J Obstet Gynecol; 1980 Aug; 137(7):840-2. PubMed ID: 6967698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma tocopherol and lipid levels in pregnancy and oral contraceptive users.
    Jagadeesan V; Prema K
    Br J Obstet Gynaecol; 1980 Oct; 87(10):903-7. PubMed ID: 7426489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of oral contraceptives on rhythmic urinary metal excretion.
    Weinmann S; Dawson EB; Smolensky MH; Weisberg RF; Lane B; Bryan S
    Am J Obstet Gynecol; 1976 Apr; 124(7):719-22. PubMed ID: 1258930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.